Company Overview
- Headquarters
- New York, NY 10036, US, New York NY
- Website
- kinevant.com
- Employees
- 14
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$10B
Who is Kinevant Sciences
Kinevant Sciences is a small company based in New York, New York, specializing in the development of high-impact medicines. With 14 employees, Kinevant Sciences focuses its efforts on transforming the lives of individuals living with rare inflammatory diseases. The company's primary product candidate, namilumab, is an investigational monoclonal antibody designed for the treatment of sarcoidosis. Namilumab targets GM-CSF, a pro-inflammatory cytokine implicated in the development of sarcoidosis and other inflammatory disorders. Kinevant Sciences is currently conducting two clinical trials to evaluate namilumab's effectiveness as a potential treatment for sarcoidosis, aiming to significantly enhance the overall quality of life for patients. Kinevant Sciences distinguishes itself through its patient-centric approach, combining scientific rigor and clinical excellence. The company strives to overcome barriers to treatment for underserved populations by delivering safe, well-tolerated, and readily accessible disease-modifying therapeutics. For more information, visit kinevant.com.
Kinevant Sciences Industry Tags
Companies Similar to Kinevant Sciences
Analyze industry trends and opportunities by examining competitors and companies comparable to Kinevant Sciences, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
Company Name | Revenue | Number of Employees | Location | Founded in |
---|---|---|---|---|
10M | 18 | Arizona City, AZ | 1998 | |
10M | 9 | San Diego, CA | ||
10M | 6 | Campbell, CA | 2011 | |
10M | 2 | Torrington, WY | ||
10M | 1 | San Diego, CA | 2016 |